GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SCWorx Corp (NAS:WORX) » Definitions » 5-Year ROIIC %

SCWorx (SCWorx) 5-Year ROIIC % : -150.87% (As of Dec. 2022)


View and export this data going back to 2016. Start your Free Trial

What is SCWorx 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. SCWorx's 5-Year ROIIC % for the quarter that ended in Dec. 2022 was -150.87%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for SCWorx's 5-Year ROIIC % or its related term are showing as below:

WORX's 5-Year ROIIC % is ranked worse than
94.14% of 563 companies
in the Healthcare Providers & Services industry
Industry Median: 1.31 vs WORX: -150.87

SCWorx 5-Year ROIIC % Historical Data

The historical data trend for SCWorx's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCWorx 5-Year ROIIC % Chart

SCWorx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
5-Year ROIIC %
Get a 7-Day Free Trial - - - -311.39 -150.87

SCWorx Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -150.87 - - -

Competitive Comparison of SCWorx's 5-Year ROIIC %

For the Health Information Services subindustry, SCWorx's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCWorx's 5-Year ROIIC % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SCWorx's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where SCWorx's 5-Year ROIIC % falls into.



SCWorx 5-Year ROIIC % Calculation

SCWorx's 5-Year ROIIC % for the quarter that ended in Dec. 2022 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -2.127 (Dec. 2022) - -3.171 (Dec. 2017) )/( 9.171 (Dec. 2022) - 9.863 (Dec. 2017) )
=1.044/-0.692
=-150.87%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


SCWorx  (NAS:WORX) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


SCWorx 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of SCWorx's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


SCWorx (SCWorx) Business Description

Traded in Other Exchanges
Address
590 Madison Avenue, 21st Floor, New York, NY, USA, 10022
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics.
Executives
Vincent Michael Matozzo director 412 RICHARD LANE, ORANGE CT 06477
Christopher John Kohler officer: Chief Financial Officer 1149 CANTERBERRY LN, PARKER CO 80138
Steven Wallitt director C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022
John C Ferrara director C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854
Steven Ross Horowitz director 4 MELISSA COURT, MONTVILLE NJ 07045
Marc Sanford Schessel director, 10 percent owner, officer: CEO 4 JACOBS LANE, NEW PALTZ NY 12561
Irby Alton F Iii director C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104
Miller Charles Kenneth Iii director 100 METROPLEX, EDISON NJ 08817
Timothy Andrew Hannibal officer: President, COO 590 MADISON AVE, NEW YORK NY 10022
Mark Shefts director 160 SUMMIT AVE, MONTVALE NJ 07645
John C Price other: Former CFO 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Robert Steven Christie director 34 SAN MARCO STREET, WEST WINDSOR NJ 08550
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
James Thaddeus Schweikert officer: Chief Operating Officer 7783 SOARING EAGLE CT., CINCINNATI OH 45244